Dunhill Financial’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$444 Buy
205
+203
+10,150% +$40.2K ﹤0.01% 1201
2026
Q2
$405 Hold
2
– – ﹤0.01% 1167
2026
Q1
$210 Hold
2
– – ﹤0.01% 1244
2025
Q4
$172 Buy
+2
New +$131 ﹤0.01% 1163

Other funds holding RVMD

Dunhill Financial's RVMD Position: Q3 2026 in Review

Dunhill Financial increased its Revolution Medicines (RVMD) stake by 10,150% in Q3 2026, buying an estimated $40.2K and bringing the position to 205 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Dunhill Financial first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. 745 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Dunhill Financial held 205 shares of Revolution Medicines worth $444 as of Q3 2026.
  • Dunhill Financial bought 203 Revolution Medicines shares in Q3 2026, an estimated $40.2K.
  • Revolution Medicines made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1201 holding.
  • Dunhill Financial first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
  • 745 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.